MLTX NASDAQ
MoonLake Immunotherapeutics
1W: -7.4%
1M: -1.0%
3M: -6.2%
YTD: +42.7%
1Y: -56.5%
3Y: -36.3%
5Y: +71.0%
$17.05
+0.68 (+4.15%)
Weekly Expected Move ±8.1%
$15
$16
$18
$19
$20
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.3B
52W Range5.95-62.75
Volume573,908
Avg Volume1,079,188
Beta1.01
Dividend—
Analyst Ratings
Company Info
CEOJorge Santos da Silva
Employees100
SectorHealthcare
IndustryBiotechnology
IPO Date2020-10-20
Websitemoonlaketx.com
Dorfstrasse 29
Zug 6300
CH
Zug 6300
CH
41 415108022
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Latest News
FDA Aligns With MoonLake On Lead Drug Submission Plans, Stock Soars
MoonLake Immunotherapeutics (MLTX) advances SLK toward HS BLA while Q1 loss deepens - Stock Titan
MoonLake Immunotherapeutics GAAP EPS of -$0.98 misses by $0.07
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bodenstedt Matthias | S-Sale | 13,653 | $20.02 | 2026-05-11 |
| Bodenstedt Matthias | S-Sale | 2,426 | $19.56 | 2026-04-14 |
| Santos da Silva Jorg | S-Sale | 51,873 | $18.23 | 2026-04-13 |
| Santos da Silva Jorg | S-Sale | 98,127 | $18.41 | 2026-04-10 |
| Bodenstedt Matthias | S-Sale | 1,925 | $19.51 | 2026-04-10 |